Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

NCT04388904 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (FDC)

Sponsor

The Crofoot Research Center, Inc.

Collaborators

[object Object]